Management of anaphylaxis due to COVID-19 vaccines in the elderly
Jazyk angličtina Země Dánsko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
N/A
ARIA
PubMed
33811358
PubMed Central
PMC8251336
DOI
10.1111/all.14838
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19 vaccines, adrenaline, anaphylaxis, older (adults/people),
- MeSH
- adrenalin MeSH
- anafylaxe * etiologie prevence a kontrola MeSH
- COVID-19 * MeSH
- lidé MeSH
- SARS-CoV-2 MeSH
- senioři MeSH
- vakcíny proti COVID-19 MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- adrenalin MeSH
- vakcíny proti COVID-19 MeSH
Older adults, especially men and/or those with diabetes, hypertension, and/or obesity, are prone to severe COVID-19. In some countries, older adults, particularly those residing in nursing homes, have been prioritized to receive COVID-19 vaccines due to high risk of death. In very rare instances, the COVID-19 vaccines can induce anaphylaxis, and the management of anaphylaxis in older people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis and its Impact on Asthma, European Academy of Allergy and Clinical Immunology, and European Geriatric Medicine Society) Working Group has proposed some recommendations for older adults receiving the COVID-19 vaccines. Anaphylaxis to COVID-19 vaccines is extremely rare (from 1 per 100,000 to 5 per million injections). Symptoms are similar in younger and older adults but they tend to be more severe in the older patients. Adrenaline is the mainstay treatment and should be readily available. A flowchart is proposed to manage anaphylaxis in the older patients.
Aix Marseille University IRD APHM MEPHI Marseille France
ALL MED Medical Research Institute Wroclaw Poland
ALL MED Medical Research Institute Wrocław Poland
Allergy and Clinical Immunology Imperial College London London UK
Allergy and Clinical Immunology Unit Centro Hospitalar e Universitário de Coimbra Coimbra Portugal
Allergy and Respiratory Diseases Ospedale Policlino San Martino University of Genoa Genoa Italy
Allergy Center CUF Descobertas Hospital Lisbon Portugal
Allergy Department Hospital Clínico San Carlos UCM IdISSC Madrid Spain
Allergy Research Group Instituto de Investigación Biomedica de Malaga IBIMA and ARADyAL Malaga Spain
Allergy Section Department of Internal Medicine Hospital Vall d'Hebron Barcelona Spain
Allergy Unit CUF Porto Porto Portugal
Allergy Unit Hospital Regional Universitario de Malaga Malaga Spain
Allergy Unit Málaga Regional University Hospital IBIMA Málaga Spain
ARADyAL Research Network Barcelona Spain
Asian Hospital and Medical Center Manilla Philippines
Asthma UK Centre for Allergic Mechanisms in Asthma London UK
Austria Outpatient Allergy Clinic Reumannplatz Vienna Austria
Center for Rhinology and Allergology Wiesbaden Germany
Children's Allergy Service Evelina London Children's Hospital Guy'sand St Thomas Hospital London UK
Children's Hospital Srebrnjak Zagreb Croatia
Christine Kühne Center for Allergy Research and Education CK CARE Davos Switzerland
Clinical Emergency Hospital for Children MS Curie Bucharest Romania
Department of Allergology Medical University of Gdańsk Gdańsk Poland
Department of Allergology Zhongnan Hospital of Wuhan University Wuhan China
Department of Allergy Al Rashed Allergy Center Kuwait City Kuwait
Department of Biomedical Sciences Humanitas University Milan Italy
Department of Clinical Immunology and Allergy Oncology Institute of St Elisabeth Bratislava Slovakia
Department of Clinical Immunology Wroclaw Medical University Wroclaw Poland
Department of Clinical Immunology Wrocław Medical University Wroclaw Poland
Department of Dermatology and Venerology Medical University of Graz Graz Austria
Department of ENT Diseases Karolinska University Hospital Stockholm Sweden
Department of Geriatrics CHRU de Nancy and Inserm DCAC Université de Lorraine Nancy France
Department of Geriatrics Montpellier University Hospital Montpellier France
Department of Infectiology Montpellier University Hospital Montpellier France
Department of Infection and Immunity Luxembourg Institute of Health Esch sur Alzette Luxembourg
Department of Internal Medicine University Hospital Ospedali Riuniti di Ancona Ancona Italy
Department of Otolaryngology Head and Neck Surgery Eye and Ear University Hospital Beirut Lebanon
Department of Otolaryngology Head and Neck Surgery Universitätsmedizin Mainz Mainz Germany
Department of Otorhinolaryngology Academic Medical Centers AMC Amsterdam The Netherland
Department of Otorhinolaryngology Chiba University Hospital Chiba Japan
Department of Otorhinolaryngology Head and Neck Surgery Semmelweis University Budapest Hungary
Department of Pediatrics Medical School Federal University of Minas Gerais Belo Horizonte Brazil
Department of Pulmonary Diseases Faculty of Medicine Celal Bayar University Manisa Turkey
Department of Pulmonary Medicine CHU Sart Tilman GIGA I3 Research Group Liege Belgium
Department of Respiratory Diseases and Allergy Aarhus University Hospital Aarhus Denmark
Department of Respiratory Medicine University Hospital Olomouc Olomouc Czech Republic
Director of Center of Allergy Immunology and Respiratory Diseases Santa Fe Argentina
Division of Allergy Asthma and Clinical Immunology Emek Medical Center Afula Israel
Division of Allergy Immunology University of South Florida Tampa FL USA
Division of ENT Diseases CLINTEC Karolinska Institutet Stockholm Sweden
Division of Service de Dermatologie et Allergologie Hôpital Tenon Paris France
Division Paediatric Allergology University of Cape Town Cape Town South Africa
Ecole polytechnique Palaiseau IRBA Bretigny France
EFA European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium
European Academy of Paediatrics (EAP UEMS SP Brussels Belgium
Faculdade de Ciências Médicas CEDOC Universidade Nova de Lisboa Lisbon Portugal
Faculty of Medicine Fundacion Jimenez Diaz CIBERES Autonoma University of Madrid Madrid Spain
Faculty of Medicine Transylvania University Brasov Romania
Faculty of Medicine University Children's Hospital University of Belgrade Belgrade Serbia
Faculty of Public Health Medical University Sofia Bulgaria
Federal University of Pampa Uruguaiana Brazil
Fondazione Mediterranea GB Morgagni Catania Italy
Fundação ProAR Federal University of Bahia and GARD WHO Planning Group Salvador BA Brazil
Geriatria Accettazione Geriatrica e Centro di Ricerca per l'invecchiamento IRCCS INRCA Ancona Italy
Gérontopôle de Toulouse INSERM 1027 Toulouse France
Hospital of the Hospitaller Brothers in Buda Budapest Hungary
IHU Méditerranée Infection Marseille and IDESP INSERM University of Montpellier Montpellier France
Immunoallergology Unit Careggi University Hospital Florence Italy
Immunomodulation and Tolerance Group Imperial College London London UK
Institute of Clinical Medicine Aarhus University Aarhus Denmark
Institute of Immunology Faculty of Medicine University of Coimbra Coimbra Portugal
Institute of Translational Pharmacology Italian National Research Council Rome Italy
International Airway Research Center Sun Yat sen University 1st Affiliated Hospital Guangzou China
International Primary Care Respiratory Group IPCRG Aberdeen UK
IRCCS Humanitas Research Hospital Personalized Medicine Asthma and Allergy Milan Italy
LANUA International Healthcare Consultancy Down UK
MACVIA France Montpellier France
Medical Consulting Czarlewski Levallois France
Medical Faculty University Clinic of Pulmology and Allergy Skopje Republic of Macedonia
Medical University of Graz Graz Austria
Microbiology Department Faculty of Medicine Kuwait University Kuwait City Kuwait
Nova Southeastern University Fort Lauderdale FL USA
Oasi Research Institute IRCCS Troina Italy
Paul Ehrlich Institut Langen Germany
Pediatric Allergy and Immunology Unit Children's Hospital Ain Shams University Cairo Egypt
Primary Care and Population Sciences University of Southampton Southampton UK
PROMISE Department University of Palermo Palermo Italy
Rappaport Faculty of Medicine Technion Israel Institute of Technology Haifa Israel
Regional Ministry of Health of Andalusia Seville Spain
Rhinology Unit and Smell Clinic ENT Department Hospital Clínic Barcelona Spain
Royal Brompton and Harefield NHS Foundation Trust London UK
School of Medicine University CEU San Pablo Madrid Spain
School of Medicine University J J Strossmayer Osijek Croatia
Service de Gériatrie CHRU Nice France
Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina
Société Française de Gériatrie et Gérontologie Paris France
SOS Allergology and Clinical Immunology USL Toscana Centro Prato Italy
Swiss Institute of Allergy and Asthma Research University of Zurich Davos Switzerland
Tartu University Institute of Clinical Medicine Children's Clinic Tartu Estonia
The Allergy and Asthma Institute Islamabad Pakistan
Ukrainina Medical Stomatological Academy Poltava Ukraine
Universidad Católica de Córdoba Universidad Nacional de Villa Maria Villa Maria Argentina
University Clinic of Respiratory and Allergic Diseases Golnik Slovenia
University Hospital Montpellier France
University Hospital Sv Ivan Rilski' Sofia Bulgaria
University of Bari Medical School Unit of Geriatric Immunoallergology Bari Italy
University of Medicine and Pharmacy Hochiminh City Vietnam
Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
Usher Institute The University of Edinburgh Edinburgh UK
Woolcock Emphysema Centre Sydney Local Health District Glebe NSW Australia
Woolcock Institute of Medical Research University of Sydney Glebe NSW Australia
Zobrazit více v PubMed
Esteve A, Permanyer I, Boertien D, Vaupel JW. National age and coresidence patterns shape COVID‐19 vulnerability. Proc Natl Acad Sci U S A. 2020;117(28):16118‐16120. PubMed PMC
Giangreco G. Case fatality rate analysis of Italian COVID‐19 outbreak. J Med Virol. 2020;92(7):919‐923. PubMed PMC
Mantovani A, Dalbeni A, Beatrice G. Coronavirus disease 2019 (COVID‐19): we don't leave women alone. Int J Public Health. 2020;65(3):235‐236. PubMed PMC
Iaccarino G, Grassi G, Borghi C, et al. Age and multimorbidity predict death among COVID‐19 patients: results of the SARS‐RAS study of the Italian Society of Hypertension. Hypertension 2020;76(2):366‐372. PubMed
Finucane FM, Davenport C. Coronavirus and obesity: could insulin resistance mediate the severity of COVID‐19 infection? Front Public Health. 2020;8:184. PubMed PMC
Klein SL, Dhakal S, Ursin RL, Deshpande S, Sandberg K, Mauvais‐Jarvis F. Biological sex impacts COVID‐19 outcomes. PLoS Pathog. 2020;16(6):e1008570. PubMed PMC
Gebhard C, Regitz‐Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID‐19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29. PubMed PMC
Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID‐19 cases: a meta‐analysis with 55 studies and 10014 cases. Heliyon. 2020;6(12):e05684. PubMed PMC
Scortichini M, Schneider Dos Santos R, De’ Donato F, et al. Excess mortality during the COVID‐19 outbreak in Italy: a two‐stage interrupted time‐series analysis. Int J Epidemiol. 2021;49(6):1909–1917. PubMed PMC
Pranata R, Henrina J, Lim MA, et al. Clinical frailty scale and mortality in COVID‐19: A systematic review and dose‐response meta‐analysis. Arch Gerontol Geriatr. 2020;93:104324. PubMed PMC
Hewitt J, Carter B, Vilches‐Moraga A, et al. The effect of frailty on survival in patients with COVID‐19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):e444‐e451. PubMed PMC
McMichael TM, Currie DW, Clark S, et al. Epidemiology of COVID‐19 in a long‐term care facility in King County, Washington. N Engl J Med. 2020;382(21):2005–2011. PubMed PMC
Blain H, Rolland Y, Tuaillon E, et al. Efficacy of a test‐retest strategy in residents and health care personnel of a nursing home facing a COVID‐19 outbreak. J Am Med Dir Assoc. 2020;21(7):933‐936. PubMed PMC
Telford CT, Onwubiko U, Holland D, et al. Mass screening for SARS‐CoV‐2 infection among residents and staff in twenty‐eight long‐term care facilities in Fulton County, Georgia. medRxiv 2020. 10.1101/2020.07.01.20144162 DOI
He M, Li Y, Fang F. Is there a link between nursing home reported quality and COVID‐19 cases? Evidence from California skilled nursing facilities. J Am Med Dir Assoc. 2020;21(7):905‐908. PubMed PMC
Grabowski DC, Mor V. Nursing home care in crisis in the wake of COVID‐19. JAMA 2020;324(1):23. PubMed
Gordon AL, Goodman C, Achterberg W, et al. Commentary: COVID in care homes‐challenges and dilemmas in healthcare delivery. Age Ageing 2020;49(5):701‐705. PubMed PMC
Blain H, Rolland Y, Schols J, et al. August 2020 interim EuGMS guidance to prepare European long‐term care facilities for COVID‐19. Eur Geriatr Med. 2020;11(6):899‐913. PubMed PMC
Banerji A, Wickner PG, Saff R, et al. mRNA vaccines to prevent COVID‐19 disease and reported allergic reactions: current evidence and approach. J Allergy Clin Immunol Pract 2021;9(4):1423–1437. PubMed PMC
Garvey LH, Nasser S. Anaphylaxis to the first COVID‐19 vaccine: is polyethylene glycol (PEG) the culprit? Br J Anaesth 2021;126(3). 10.1016/j.bja.2020.12.020. [Epub ahead of print]. PubMed DOI PMC
Klimek L, Jutel M, Akdis CA, et al. ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines ‐ an EAACI‐ARIA position paper. Allergy. 2021;76(6):1624‐1628. PubMed
Ventura MT, Boni E, Cecere R, et al. Importance of hypersensitivity in adverse reactions to drugs in the elderly. Clin Mol Allergy. 2018;16:7. PubMed PMC
Ruggeberg JU, Gold MS, Bayas JM, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25(31):5675‐5684. PubMed
Su JR, Moro PL, Ng CS, Lewis PW, Said MA, Cano MV. Anaphylaxis after vaccination reported to the vaccine adverse event reporting system, 1990–2016. J Allergy Clin Immunol. 2019;143(4):1465‐1473. PubMed PMC
Shimabukuro T. COVID‐19 vaccine safety update. Advisory Committee on Immunization Practices (ACIP) January 27, 2021. National Center for Immunization and respiratory diseases CDC https://wwwcdcgov/vaccines/acip/meetings/downloads/slides‐2021‐01/06‐COVID‐Shimabukuropdf. 2021.
Cabanillas B, Akdis C, Novak N. Allergic reactions to the first COVID‐19 vaccine: a potential role of Polyethylene glycol? Allergy 2021;76(6):1617‐1618. PubMed
Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer‐BioNTech COVID‐19 vaccine. JAMA 2021;325(8):780. PubMed PMC
Klimek L, Novak N, Cabanillas B, Jutel M, Bousquet J, Akdis CA. Allergenic components of the mRNA‐1273 vaccine for COVID‐19: Possible involvement of polyethlene glycol and IgG‐mediated complement activation. Allergy 2021. 10.1111/all.14794 PubMed DOI PMC
Sokolowska M, Eiwegger T, Ollert M, et al. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines. Allergy 2021;76(6):1629‐1639. PubMed PMC
Aurich S, Dolle‐Bierke S, Francuzik W, et al. Anaphylaxis in elderly patients‐data from the European anaphylaxis registry. Front Immunol. 2019;10:750. PubMed PMC
Campbell RL, Hagan JB, Li JT, et al. Anaphylaxis in emergency department patients 50 or 65 years or older. Ann Allergy Asthma Immunol. 2011;106(5):401‐406. PubMed
Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1(8009):466‐469. PubMed
Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States. 1999‐2010: temporal patterns and demographic associations. J Allergy Clin Immunol. 2014;134(6):1318‐1328.e7. PubMed PMC
Niggemann B, Beyer K. Time for a new grading system for allergic reactions? Allergy. 2016;71(2):135‐136. PubMed
Muraro A, Fernandez‐Rivas M, Beyer K, et al. The urgent need for a harmonized severity scoring system for acute allergic reactions. Allergy. 2018;73(9):1792‐1800. PubMed
Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63(2):226‐232. PubMed
Dolle‐Bierke S, Siebenhaar F, Burmeister T, Worm M. Detection of KIT D816V mutation in patients with severe anaphylaxis and normal basal tryptase‐first data from the Anaphylaxis Registry (NORA). J Allergy Clin Immunol. 2019;144(5):1448‐1450.e1. PubMed
Worm M, Francuzik W, Renaudin JM, et al. Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from The European Anaphylaxis Registry. Allergy. 2018;73(6):1322‐1330. PubMed
Bilo MB, Martini M, Tontini C, Corsi A, Antonicelli L. Anaphylaxis. Eur Ann Allergy Clin Immunol. 2020;53(01):4. PubMed
Lieberman P, Simons FE. Anaphylaxis and cardiovascular disease: therapeutic dilemmas. Clin Exp Allergy. 2015;45(8):1288‐1295. PubMed
Tejedor‐Alonso MA, Farias‐Aquino E, Perez‐Fernandez E, Grifol‐Clar E, Moro‐Moro M, Rosado‐Ingelmo A. Relationship between anaphylaxis and use of beta‐blockers and angiotensin‐converting enzyme inhibitors: a systematic review and meta‐analysis of observational studies. J Allergy Clin Immunol Pract. 2019;7(3):879‐897.e5. PubMed
Thim T, Krarup NH, Grove EL, Rohde CV, Lofgren B. Initial assessment and treatment with the Airway, Breathing, Circulation, Disability, Exposure (ABCDE) approach. Int J Gen Med. 2012;5:117‐121. PubMed PMC
Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026‐1045. PubMed
Simons FE, Ebisawa M, Sanchez‐Borges M, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;8(1):32. PubMed PMC
Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010;10(4):354‐361. PubMed
Campbell RL, Bellolio MF, Knutson BD, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015;3(1):76‐80. PubMed
Bilo MB, Cichocka‐Jarosz E, Pumphrey R, et al. Self‐medication of anaphylactic reactions due to Hymenoptera stings‐an EAACI Task Force Consensus Statement. Allergy. 2016;71(7):931‐943. PubMed
O'Brien ME, Koehl JL, Raja AS, Erickson TB, Hayes BD. Age‐related cardiovascular outcomes in older adults receiving epinephrine for anaphylaxis in the emergency department. J Allergy Clin Immunol Pract. 2019;7(8):2888‐2890. PubMed
Rukma P. Glucagon for refractory anaphylaxis. Am J Ther. 2019;26(6):e755‐e756. PubMed
McLure M, Eastwood K, Parr M, Bray J. A Rapid review of advanced life support guidelines for cardiac arrest associated with anaphylaxis. Resuscitation 2021;159:137–149. PubMed
Lieberman PL. Recognition and first‐line treatment of anaphylaxis. Am J Med. 2014;127(1 Suppl):S6‐11. PubMed
Ring J, Beyer K, Biedermann T, et al. Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB). Allergo J Int. 2014;23(3):96‐112. PubMed PMC